Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease: Results from a Phase 1 Randomized Trial

Detalles Bibliográficos
Autores principales: Zhang, Wenhui, Scalori, Astrid, Fuh, Franklin, McBride, Jacqueline, She, Gaohong, Kierkus, Jaroslaw, Korczowski, Bartosz, Li, Regan, Abouhossein, Mariam, Kadva, Alysha, Park, K T, Tang, Meina Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Corrections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527608/
https://www.ncbi.nlm.nih.gov/pubmed/35366308
http://dx.doi.org/10.1093/ibd/izac066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527608/
https://www.ncbi.nlm.nih.gov/pubmed/35366308
http://dx.doi.org/10.1093/ibd/izac066

Ejemplares similares